Doctor Anna Slattman

Skane University Hospital, Lund (Sweden)

Follow

Contributor content

Pacemaker implantation due to cardiac conduction disease in patients with subsequent cardiac sarcoidosis may be a marker of early disease and is associated with adverse 5-year clinical outcome

Presentation

Pacemaker implantation due to cardiac conduction disease in patients with subsequent cardiac sarcoidosis may be a marker of early disease and is associated with adverse 5-year clinical outcome

ESC 365 is supported by

novartis

Explore sponsored resources